Playback speed
10 seconds
Therapeutic Approach for CLL Biomarkers: Low-Risk Should Be Treated w/ anti-CD20+Chlorambucil, High-Risk w/ BCRis, Venetoclax, or Combos
220 views
December 20, 2019
Login to view comments.
Click here to Login